Bolivia, Plurinational State of vs Peru: HIV-positive TB patients on ART (antiretroviral therapy)
Bolivia, Plurinational State of
65.0%
in 2024
Peru
57.0%
in 2024
Bolivia, Plurinational State of rank
134th
Peru rank
137th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bolivia, Plurinational State of
- Peru
How they compare
Bolivia, Plurinational State of currently reports 65.0% against 57.0% in Peru, a difference of 8.0%.
That makes Bolivia, Plurinational State of's figure about 1.1 times Peru's.
The two have swapped places 10 times across 13 shared years of data; in 2007 it was Bolivia, Plurinational State of ahead.
Bolivia, Plurinational State of ranks 134th and Peru ranks 137th of 144 countries.
Bolivia, Plurinational State of has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 64.0% | 12.6% | 51.4% | Bolivia, Plurinational State of |
| 2010s | 69.5% | 62.8% | 6.7% | Bolivia, Plurinational State of |
| 2020s | 59.0% | 55.0% | 4.0% | Bolivia, Plurinational State of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bolivia, Plurinational State of or Peru?
- Bolivia, Plurinational State of, at 65.0% against 57.0% in Peru as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bolivia, Plurinational State of and Peru?
- 8.0%, with Bolivia, Plurinational State of ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Peru?
- 13 years are reported by both, from 2007 to 2024.
- How do Bolivia, Plurinational State of and Peru rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bolivia, Plurinational State of ranks 134th and Peru ranks 137th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.